Search
Phenazopyridine
go.drugbank.com/drugs/DB01438ApprovedInvestigationalIngestion of phenazopyridine is found to change the appearance of the urine by imparting an orange or red color, as it is considered an azo dye.[L7829] … In the USA, this drug was previously marked by Roche but has been discontinued by the FDA.[L7832] It is still used in various parts of the world.
Efanesoctocog alfa
go.drugbank.com/drugs/DB16662ApprovedInvestigationalEndogenous VWF protects FVIII from degradation but also sets a half-life of approximately 15 to 19 h. … [A257464,A257469] In February 2023, efanesoctocog alfa was approved by the FDA as a new class of factor VIII therapy for hemophilia A.[L45379,L45414]
Deutivacaftor
go.drugbank.com/drugs/DB15141ApprovedInvestigational[L52275,A179677] Deutivacaftor was first approved by the US FDA in December 2024 in combination with two CFTR correctors - [tezacaftor] and [vanzacaftor] - for the treatment of patients with responsive … It is used alongside CFTR correctors to increase the quantity and function of CFTR at the cell surface in patients with cystic fibrosis.
Methadone
go.drugbank.com/drugs/DB00333ApprovedInvestigationalUse of OAT is also intended to lead to social stabilization by reducing crime rates, incarceration, use of illicit opioids such as [heroin] or [fentanyl], and ultimately marginalization. … [F4685,F4688,F4691,A185885,A185900,A185903] Due to its unique mechanism of action, methadone is particularly useful for the management of hard to treat pain syndromes such as neuropathic pain and cancer
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeAnakinra
go.drugbank.com/drugs/DB00026ApprovedInvestigationalOn November 14, 2001, it was approved by the FDA for the treatment of rheumatoid arthritis. … [A247265] On November 8, 2022, the FDA issued an emergency use authorization (EUA) of anakinra for the treatment of COVID-19 in hospitalized patients who are at risk of progressing to severe respiratory
Categories: Biologics for Rheumatoid Arthritis TreatmentAdenosine Deaminase Deficiency
go.drugbank.com/conditions/DBCOND0051206Drugs: PegademaseSynonyms: Severe combined immunodeficiency due to adenosine deaminase deficiencyNeuroborreliosis, Borrelia Burgdorferi
go.drugbank.com/conditions/DBCOND0078182Drugs: CeftriaxoneSynonyms: Infection due to Borrelia burgdorferi sensu latoOpium
go.drugbank.com/drugs/DB11130ApprovedIllicitDuring the years, opium was used as a sedative and hypnotic, but it was determined to be addictive.[A32171] Opium is extracted from _Papaver somniferum_, which is more known as poppies. … It has been known for a long time, and the first evidence of a poppy culture dates from 5 thousand years by the Sumerians.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeRiociguat
go.drugbank.com/drugs/DB08931ApprovedInvestigationalRiociguat is marketed under the brand Adempas® by Bayer HealthCare Pharmaceuticals. Treatment with riociguat costs USD $7,500 for 30 days of treatment. … Riociguat is a soluble guanylate cyclase (sGC) agonist approved in the USA, Europe and several other regions for patients with group I PAH (pulmonary arterial hypertension) in WHO FC II or III; and for
Categories: Antihypertensives for Pulmonary Arterial HypertensionGlycogen Storage Disease Type II
go.drugbank.com/conditions/DBCOND0002595Synonyms: Glycogenosis due to acid maltase deficiency, Glycogen storage disease due to acid maltase deficiency (disorder)